Review
Open access
Sep 2026
The path to treating multiple-etiology dementia: Combining vascular risk control and disease-modifying neurodegenerative therapies
An integrated research roadmap for MED is proposed that prioritizes biomarker-enriched cohorts, combination vascular and neurodegenerative therapies, and pragmatic trials, and offers the most plausible strategy to reduce the growing global burden of MED.
Adam de Havenon, Kevin N. Sheth, Carolyn A. Fredericks et al.
· Neurotherapeutics · 0 citations